Ranbezolid
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
N-{[(5S)-3-(3-Fluoro-4-{4-[(5-nitro-2-furyl)methyl]-1-piperazinyl}phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide | |
Clinical data | |
Legal status | ? |
Identifiers | |
ATC code | ? |
PubChem | CID 496993 |
ChemSpider | 435159 |
ChEMBL | CHEMBL251384 |
Synonyms | RBX-7644 |
Chemical data | |
Formula | H24FN5O6 |
Mol. mass | 461.4 g/mol |
SMILES
| |
| |
Ranbezolid is a novel oxazolidinone antibacterial. It competitively inhibits monoamine oxidase-A (MAO-A).[1]
References
- ↑ European Journal of Pharmacology. 2006. 545, 167–172
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.